KEYNOTE-021 cohorts D and H suggest modest benefit in combining ipilimumab with pembrolizumab in second-line or later advanced non-small cell lung cancer treatment

by Cummings, Amy Lauren, Santoso, Kate M., Goldman, Jonathan W.
Published in Transl Lung Cancer Res (2019)